skip to navigation skip to content

Business Weekly: Cambridge Gates scholar targets brain cancer with new drugs


An interview with Minaam Abbas, CEO of startup angioClast. The company is developing products targeting Glioblastoma Multiforme, the most aggressive and incurable brain cancer. The startup is supported by the Accelerate Cambridge programme at Cambridge Judge’s Entrepreneurship Centre.

Read the full article []